Healio#health
FDA approves Tauklarify for PET imaging of tau neurofibrillary tangle pathologytranslating…
1h agoFactuality: 74/100USAHealio (SLACK Incorporated)
The FDA has approved Tauklarify as a radiodiagnostic agent for adults with cognitive impairment being evaluated via PET scan to identify tau neurofibrillary tangle pathology indicating Alzheimer’s disease, according to a press release.